MBS item

61530
=====

Whole body 68Ga-DOTA-somatostatin receptor PET imaging for staging surgically incurable neuroendocrine tumours, assessing somatostatin receptor expression before peptide receptor radionuclide therapy, evaluating therapy response, or detecting recurre…

Category 5 · Diagnostic imaging services[Group I4 · subgroup 2](/groups/I4)

Schedule fee$953.00

100% benefitGP, out of hospital—

85% benefitOut of hospital$848.50

75% benefitIn hospital$714.75

The schedule fee for MBS item 61530 is $953.00. Medicare pays $848.50 (85%) out of hospital, or $714.75 (75%) for a privately admitted patient in hospital. Fee effective 1 November 2025.

Gap for what you charge
-----------------------

Your fee$

Out of hospitalIn hospital (private)

Medicare pays$848.50

Patient gap$104.50

Bulk billing means accepting $848.50 as full payment, with no gap and no extra charges. [Add incentives](/bulk-billing?item=61530)

Item descriptor
---------------

Whole body 68Ga-DOTA-somatostatin receptor agonist PET study for: a) staging of histologically confirmed neuroendocrine neoplasm (NEN) considered surgically incurable on conventional imaging, orb) evaluation of somatostatin receptor expression of histologically confirmed and inoperable NEN, either locally advanced or metastatic, under consideration for peptide receptor radionuclide therapy (PRRT); orc) evaluation of response to PRRT therapy; ord) evaluation of suspected recurrent or metastatic disease in known somatostatin receptor positive NEN. (R) (Anaes.)

[Explanatory notes and rules on MBS Online ↗](https://www9.health.gov.au/mbs/fullDisplay.cfm?type=item&q=61530)

Health fund and DVA rates
-------------------------

Total fee each scheme recognises for this item in hospital.

StateNSWVICQLDSAWATASACTNT

Guides
------

- [How Medicare benefits work: schedule fees, 75%, 85% and 100%](/guides/how-medicare-benefits-work)
- [Medicare safety nets explained: original and extended (EMSN) thresholds for 2026](/guides/medicare-safety-nets)
- [In-hospital billing: the 75% benefit, the 25% fund benefit, and no-gap and known-gap schemes](/guides/in-hospital-billing-and-gap-cover)
- [Bulk billing incentives and BBPIP explained: 2026 amounts by MM area](/guides/bulk-billing-incentives)
- [The MBS multiple operation rule and surgical assistant fees](/guides/multiple-operation-rule)
- [Assignment of benefit for bulk billing: the changes from 1 July 2026](/guides/assignment-of-benefit-2026)
- [MBS telehealth rules: the eligible telehealth practitioner and phone items](/guides/mbs-telehealth-rules)
- [GP chronic condition management plans: items 965 and 967 explained](/guides/chronic-condition-management-plans)
- [Medicare billing compliance: claim time limits, records and the 80/20 rule](/guides/medicare-billing-compliance)

Data source: [Australian Government Medicare Benefits Schedule](https://www.mbsonline.gov.au/) · Record updated 1 September 2026. Health fund rates come from each fund's published schedule. Verify item descriptors, rules and fees on [MBS Online](https://www9.health.gov.au/mbs/fullDisplay.cfm?type=item&q=61530) before billing. This is a reference tool, not billing or financial advice.